Cocrystal Pharma, Inc. (COCP) shares rose 14.23 percent to $1.64 on Friday, adding$0.20, after the company announced it had entered into definitive agreements for a registered direct offering of 2.76 million shares at $1.70 per share, along with a concurrent private placement of unregistered warrants to purchase up to 5.53 million shares at$1.50 per share. The stock opened at $2.45 and traded between$1.54 and $2.67, compared with a prior close of$1.44 on the Nasdaq. Trading volume surged to 79.3 milli ...